The survival benefit of deceased donor kidney transplantation for Aboriginal and Torres Strait Islander people, 2006–20: a retrospective national cohort study

Abstract

AbstractObjectivesTo quantify the survival benefit of kidney transplantation for Aboriginal and Torres Strait Islander people waitlisted for deceased donor kidney transplantation in Australia.Study designRetrospective cohort study; analysis of linked data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry, the Australia and New Zealand Organ Donation (ANZOD) registry, and OrganMatch (Australian Red Cross).Setting, participantsAll adult Aboriginal and Torres Strait Islander people (18 years or older) who commenced dialysis in Australia during 1 July 2006 – 31 December 2020 and were included in the kidney‐only deceased donor transplant waiting list.Main outcome measuresSurvival benefit of deceased donor kidney transplantation relative to remaining on dialysis.ResultsOf the 4082 Aboriginal and Torres Strait Islander people who commenced dialysis, 450 were waitlisted for kidney transplants (11%), of whom 323 received deceased donor transplants. Transplantation was associated with a significant survival benefit compared with remaining on dialysis after the first 12 months (adjusted hazard ratio [HR], 0.38; 95% confidence interval [CI], 0.20–0.73). This benefit was similar to that for waitlisted non‐Indigenous people who received deceased donor kidney transplants (adjusted HR, 0.47; 95% CI, 0.40–0.57; Indigenous status interaction: P = 0.22).ConclusionsFrom twelve months post‐transplantation, deceased donor transplantation provides a survival benefit for Aboriginal and Torres Strait Islander people. Our findings provide evidence that supports efforts to promote the waitlisting of Aboriginal and Torres Strait Islander people who are otherwise eligible for transplantation.